作者: John H. Sampson , Amy B. Heimberger , Gary E. Archer , Kenneth D. Aldape , Allan H. Friedman
关键词: Gene mutation 、 Dacarbazine 、 Temozolomide 、 DNA methylation 、 Mutation 、 Immunology 、 Regulation of gene expression 、 Epidermal growth factor receptor 、 Medicine 、 Immunohistochemistry
摘要: Purpose Immunologic targeting of tumor-specific gene mutations may allow precise eradication neoplastic cells without toxicity. Epidermal growth factor receptor variant III (EGFRvIII )i s a constitutively activated and immunogenic mutation not expressed in normal tissues but widely glioblastoma multiforme (GBM) other neoplasms.